AWM
ATYR

Alterna Wealth Management’s aTyr Pharma ATYR Stock Holding History

Alterna Wealth Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$30.2K – 126
2025
Q1 		$30.2K Hold
10,000
– – 0.02% 108
2024
Q4 		$36.2K Hold
10,000
– – 0.03% 102
2024
Q3 		$17.6K Hold
10,000
– – 0.02% 101
2024
Q2 		$15.6K Hold
10,000
– – 0.01% 105
2024
Q1 		$19.5K Hold
10,000
– – 0.02% 94
2023
Q4 		$14.1K Hold
10,000
– – 0.02% 76
2023
Q3 		$15.8K Hold
10,000
– – 0.02% 71
2023
Q2 		$21.6K Buy
+10,000
New +$21.8K 0.03% 106

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alterna Wealth Management's ATYR Position: Q2 2025 in Review

Alterna Wealth Management sold out of aTyr Pharma (ATYR) in Q2 2025, closing a stake of 10,000 shares — an estimated $30.2K sold.

Alterna Wealth Management first reported a position in ATYR in Q2 2023 and held it in 8 quarters. The position peaked at $36.2K in Q4 2024. 110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • Alterna Wealth Management reported no remaining aTyr Pharma position as of Q2 2025 after selling out during the quarter.
  • Alterna Wealth Management sold 10,000 aTyr Pharma shares in Q2 2025, an estimated $30.2K.
  • Alterna Wealth Management first reported a position in aTyr Pharma in Q2 2023 and held it in 8 quarters.
  • Alterna Wealth Management's aTyr Pharma position peaked at $36.2K in Q4 2024.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on Alterna Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.